Maria Saigí

7PUBLICATIONS
52CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 12, 2024
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?

Sviatoslav Chekhun, Assumpció Lopez-Paradís, Aintzane Urbizu

|Sep 06, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.

Ryohei Yoshida, Maria Saigi, Tetsuo Tani

|Sep 30, 2021
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.

Elisabet Aliagas, Ania Alay, Maria Martínez-Iniesta

|Jul 15, 2021
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.

Octavio A Romero, Andrea Vilarrubi, Juan J Alburquerque-Bejar

|Mar 12, 2021
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity.

Navin R Mahadevan, Erik H Knelson, Jacquelyn O Wolff

|Dec 07, 2019
Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas.

Carmen Salvador-Coloma, María Saigí, Roberto Díaz-Beveridge

Pageof 2

Frequent Collaborators

2 joint publications

Erik H Knelson

2 joint publications

Amir Vajdi

2 joint publications

Marco Campisi

2 joint publications

Patrick H Lizotte